1604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus Erythematosus

1604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus Erythematosus

Bibliographic Details
Main Authors:	Karen Costenbader, Yuqing Zhang, Hyon Choi, April Jorge, Emma Materne, Baijun Zhou
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-12-01
Series:	Lupus Science and Medicine

Similar Items

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
by: Marlene Plüß, et al.
Published: (2022-11-01)

EXPERIENCE WITH BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: E. A. Aseeva, et al.
Published: (2015-09-01)

BELIMUMAB: ADVANCES IN DRUG THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS
by: Evgeny Lvovich Nasonov, et al.
Published: (2012-10-01)

Successful treatment of systemic lupus erythematosus pleuropericarditis with belimumab
by: Irene Carrión-Barberà, et al.
Published: (2019-07-01)

Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus
by: A. G. Tolkushin, et al.
Published: (2018-11-01)

Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2020-11-01)

New possibilities of pharmacotherapy for systemic lupus erythematosus: A place of belimumab
by: E. L. Nasonov
Published: (2014-12-01)

Efficacy of a sequential treatment by belimumab in monogenic systemic lupus erythematosus
by: Lujayn Akbar, et al.
Published: (2020-10-01)

Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks
by: Michelle Petri, et al.
Published: (2023-01-01)

Letter to the Editor: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus
by: Nick Ballew, et al.
Published: (2022-12-01)

Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus
by: Ian N Bruce, et al.
Published: (2022-12-01)

Effect of belimumab in patients with systemic lupus erythematosus treated with low dose or no corticosteroids
by: Yeo-Jin Lee, et al.
Published: (2024-03-01)

Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus
by: Ioannis Parodis, et al.
Published: (2020-05-01)

Successful treatment of cardiac tamponade with systemic lupus erythematosus using belimumab and hydroxychloroquine
by: Tomoo Kise, et al.
Published: (2023-01-01)

LSO-028 Predictors of de novo renal flares in systemic lupus erythematosus – time to revisit belimumab dose for extra-renal disease? Results from five phase III clinical trials of belimumab
by: Brad Rovin, et al.
Published: (2023-07-01)

LP-189 Effect of belimumab in patients with systemic lupus erythematosus treated with minimal or no steroid
by: Ji Seon Oh, et al.
Published: (2023-07-01)

Short‐term clinical observations of belimumab in the treatment of recently diagnosed systemic lupus erythematosus
by: Chunye Wu, et al.
Published: (2022-11-01)

Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studies
by: Bangert E, et al.
Published: (2019-01-01)

High-dimensional analysis of T-cell profiling variations following belimumab treatment in systemic lupus erythematosus
by: Hiroya Hashimoto, et al.
Published: (2023-08-01)

LSO-088 Ld-IL2 synthesis with belimumab in the treatment of systemic lupus erythematosus patients
by: Ruiling Feng
Published: (2023-07-01)

Experience of long-term belimumab use in patients with systemic lupus erythematosus (a case report)
by: Natalia Gennadyevna Klyukvina
Published: (2013-06-01)

Prospects for the use of belimumab in lupus nephritis
by: N. L. Kozlovskaya, et al.
Published: (2021-08-01)

P158 Belimumab for the treatment of systemic lupus erythematosus in the real world: a single center study
by: Jorge Juan Fragío Gil, et al.
Published: (2024-03-01)

Belimumab Decreases Autophagy and Citrullination in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
by: Tania Colasanti, et al.
Published: (2022-01-01)

Belimumab in the treatment of systemic lupus erythematosus: 20 years of basic research, 10 years of clinical practice
by: E. L. Nasonov, et al.
Published: (2021-09-01)

Subcutaneous formulation of belimumab in treatment of systemic lupus erythematosus: a critical review with focus on safety and satisfaction
by: Ahmed HMA, et al.
Published: (2018-11-01)

LSO-030 Predictors of renal flares in systemic lupus erythematosus: a post-hoc analysis of four phase III clinical trials of belimumab
by: Ioannis Parodis, et al.
Published: (2023-07-01)

Urine proteomic insights from the belimumab in lupus nephritis trial
by: Daniel Goldman, et al.
Published: (2022-10-01)

RESULTS OF AN OBSERVATIONAL PROSPECTIVE STUDY OF THE EFFICACY AND SAFETY OF BELIMUMAB (BENLYSTA®) IN SYSTEMIC LUPUS ERYTHEMATOSUS IN REAL CLINICAL PRACTICE
by: E. A. Aseeva, et al.
Published: (2016-03-01)

LP-191 Baseline profile of systemic lupus erythematosus patients on treatment with belimumab of a Spanish multicenter cohort
by: Íñigo Rúa-Figueroa, et al.
Published: (2023-07-01)

The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients
by: Jing Wang, et al.
Published: (2023-02-01)

PO.6.119 Low-dose belimumab and antimalarial agents prevent renal flares in systemic lupus erythematosus: results from four randomised clinical trials
by: A Gómez, et al.
Published: (2022-10-01)

P60 Performance of SLE-DAS to assess subcutaneous belimumab efficacy in a cohort of systemic lupus erythematosus patients
by: Fabrizio Conti, et al.
Published: (2024-03-01)

P153 Real world experience with Belimumab in systemic lupus erythematosus patients in a Portuguese single center cohort
by: Carlos Vasconcelos, et al.
Published: (2024-03-01)

Concentrations of subcutaneously administered belimumab in human breast milk of a woman with systemic lupus erythematosus: a case report
by: Alexandre E Voskuyl, et al.
Published: (2024-03-01)

Humoral and T-Cell Mediated Response after the Third Dose of mRNA Vaccines in Patients with Systemic Lupus Erythematosus on Belimumab
by: Luca Quartuccio, et al.
Published: (2023-01-01)

Population model‐based analysis of the memory B‐cell response following belimumab therapy in the treatment of systemic lupus erythematosus
by: Richard Dimelow, et al.
Published: (2023-04-01)

LP-181 Effect and safety profile of belimumab and tacrolimus combination therapy in thirty-three patients with systemic lupus erythematosus
by: Masato Okada
Published: (2023-07-01)

Impact of Belimumab on Patient-Reported Outcomes in Systemic Lupus Erythematosus: Insights from Clinical Trials and Real-World Evidence
by: Gomez A, et al.
Published: (2023-01-01)

Real-World Effectiveness of Belimumab in Patients with Active Lupus
by: Yuya Sumichika, et al.
Published: (2023-12-01)